Exact Mass: 470.1664046000001

Exact Mass Matches: 470.1664046000001

Found 43 metabolites which its exact mass value is equals to given mass value 470.1664046000001, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

7-hydroxymethotrexate

(2S)-2-[(4-{[(4-amino-2-imino-7-oxo-1,2,3,7-tetrahydropteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid

C20H22N8O6 (470.1662232)


7-hydroxymethotrexate is a metabolite of methotrexate. Methotrexate, abbreviated MTX and formerly known as amethopterin, is an antimetabolite and antifolate drug. It is used in treatment of cancer, autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions. It acts by inhibiting the metabolism of folic acid. Methotrexate began to replace the more toxic antifolate aminopterin starting in the 1950s. The drug was developed by Yellapragada Subbarao. (Wikipedia) D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists

   

7-Hydroxymethotrexat

2-[[4-[(2,4-diamino-7-oxo-8H-pteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid

C20H22N8O6 (470.1662232)


D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists CONFIDENCE standard compound; INTERNAL_ID 2731 CONFIDENCE standard compound; INTERNAL_ID 8505

   

Ala Cys Phe Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C20H30N4O5S2 (470.165753)


   

Ala Cys Met Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Ala Phe Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C20H30N4O5S2 (470.165753)


   

Ala Phe Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Ala Met Cys Phe

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Ala Met Phe Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Ala Phe Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Ala Met Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Cys Phe Val

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Cys Val Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Phe Ala Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Phe Cys Val

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-3-methylbutanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Phe Met Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]propanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Phe Val Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Met Ala Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]propanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Met Phe Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]propanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Val Cys Phe

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Val Phe Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Ala Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Ala Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Cys Ala Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Cys Cys Val

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylbutanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Cys Met Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]propanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Cys Val Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-methylbutanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Met Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]propanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Met Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]propanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Val Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Met Ala Cys Phe

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Met Ala Phe Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Met Cys Ala Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]propanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Met Cys Phe Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]propanoic acid

C20H30N4O5S2 (470.165753)


   

Met Phe Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]propanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Met Phe Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]propanoic acid

C20H30N4O5S2 (470.165753)


   

Val Cys Cys Phe

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Val Cys Phe Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Val Phe Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

7-Hydroxymethotrexate

2-[[4-[(2,4-diamino-7-oxo-8H-pteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid

C20H22N8O6 (470.1662232)


D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists

   

5-Formimidoyltetrahydrofolate(2-)

5-Formimidoyltetrahydrofolate(2-)

C20H22N8O6-2 (470.1662232)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

5-Formimidoyltetrahydrofolate(2-)

5-Formimidoyltetrahydrofolate(2-)

C20H22N8O6 (470.1662232)


Dianion of 5-formimidoyltetrahydrofolic acid arising from deprotonation of both carboxylic acid functions.

   

Hydroxymethotrexate

Hydroxymethotrexate

C20H22N8O6 (470.1662232)


   

SF-22

SF-22

C28H26N2O3S (470.1664046000001)


SF-22 is a potent and brain-penetrant antagonist of neuropeptide Y receptor (Y2R), with the IC50 value of 750 nM. SF-22 plays an important role in neurological disease[1].